The Valley Desk

ArticleJournal of medicinal chemistryPublished

Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine Mimic

34 of 48 authors shown in byline order.

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source

Institution
Merck & Co.

Publication record

Type
Article
Venue
Journal of medicinal chemistry
Published
Subject terms
Humans; Amides; Cysteine Endopeptidases; Glutamine; Protease Inhibitors; Antiviral Agents; Inventions; COVID-19; SARS-CoV-2
PubMed ID
38365209
Added to directory
Source checked

Report a correction or request removal